Ask AI
ProCE Banner Activity

Mitigating and Managing AEs Associated With Newer Agents for Relapsed ES-SCLC

Slideset

Download these slides on managing and mitigating adverse events related to newer therapies for relapsed extensive-stage SCLC, with a focus on tarlatamab, lurbinectedin, and immunotherapy.

Released: December 02, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Jazz Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.